Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q57410177
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010728.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q57410177
|
024
|
|
|
‡a
0000-0001-5374-8176
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q57410177
|
100
|
0 |
|
‡a
DANIEL MARTINEZ LAGUNA
‡9
es
‡9
ast
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Daniel Martinez Laguna
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
DANIEL MARTINEZ LAGUNA
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's "Burden of osteoporotic fractures in primary health care in Catalonia
|
670
|
|
|
‡a
Author's "Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study"
|
670
|
|
|
‡a
Author's Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters
|
670
|
|
|
‡a
Author's Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study
|
670
|
|
|
‡a
Author's Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort
|
670
|
|
|
‡a
Author's Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.
|
670
|
|
|
‡a
Author's Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis.
|
670
|
|
|
‡a
Author's One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
|
670
|
|
|
‡a
Author's Preschool Obesity Is Associated With an Increased Risk of Childhood Fracture: A Longitudinal Cohort Study of 466,997 Children and Up to 11 Years of Follow-up in Catalonia, Spain
|
670
|
|
|
‡a
Author's Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case–control study
|
670
|
|
|
‡a
Author's Riesgo de fracturas en mujeres mayores de 65 años en un centro de atención primaria
|
670
|
|
|
‡a
Author's Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
|
670
|
|
|
‡a
Author's The association between fracture and obesity is site-dependent: A population-based study in postmenopausal women
|
670
|
|
|
‡a
Author's Update on osteoporosis treatment
|
670
|
|
|
‡a
Author's Validation of fragility fractures in primary care electronic medical records: A population-based study.
|
909
|
|
|
‡a
(orcid) 0000000153748176
‡9
1
|
919
|
|
|
‡a
associationbetweenfractureandobesityissitedependentapopulationbasedstudyinpostmenopausalwomen
‡A
The association between fracture and obesity is site-dependent: A population-based study in postmenopausal women
‡9
1
|
919
|
|
|
‡a
updateonosteoporosistreatment
‡A
Update on osteoporosis treatment
‡9
1
|
919
|
|
|
‡a
validationoffragilityfracturesinprimarycareelectronicmedicalrecordsapopulationbasedstudy
‡A
Validation of fragility fractures in primary care electronic medical records: A population-based study.
‡9
1
|
919
|
|
|
‡a
1and2yearpersistencewithdifferentantiosteoporosismedicationsaretrospectivecohortstudy
‡A
One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study.
‡9
1
|
919
|
|
|
‡a
preschoolobesityisassociatedwithanincreasedriskofchildhoodfracturealongitudinalcohortstudyof466997childrenandupto11yearsoffollowupincataloniaspain
‡A
Preschool Obesity Is Associated With an Increased Risk of Childhood Fracture: A Longitudinal Cohort Study of 466,997 Children and Up to 11 Years of Follow-up in Catalonia, Spain
‡9
1
|
919
|
|
|
‡a
realworldantidiabeticdruguseandfractureriskin12277patientswithtype2diabetesmellitusanestedcasecontrolstudy
‡A
Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case–control study
‡9
1
|
919
|
|
|
‡a
differentialmortalityandtheexcessratesofhipfractureassociatedwithtype2diabetesaccountingforcompetingrisksinfracturepredictionmatters
‡A
Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters
‡9
1
|
919
|
|
|
‡a
burdenofosteoporoticfracturesinprimaryhealthcareincataloniaspainapopulationbasedstudy
‡A
"Burden of osteoporotic fractures in primary health care in Catalonia (Spain): a population-based study"
‡9
1
|
919
|
|
|
‡a
burdenofosteoporoticfracturesinprimaryhealthcareincatalonia
‡A
"Burden of osteoporotic fractures in primary health care in Catalonia
‡9
1
|
919
|
|
|
‡a
riesgodefracturasenmujeresmayoresde65anosen1centrodeatencionprimaria
‡A
Riesgo de fracturas en mujeres mayores de 65 años en un centro de atención primaria
‡9
1
|
919
|
|
|
‡a
seculartrendsintheinitiationoftherapyinsecondaryfracturepreventionineuropeamultinationalcohortstudyincludingdatafromdenmarkcataloniaandtheunitedkingdom
‡A
Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom
‡9
1
|
919
|
|
|
‡a
excessofallcausemortalityafterafractureintype2diabeticpatientsapopulationbasedcohortstudy
‡A
Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study
‡9
1
|
919
|
|
|
‡a
fractureriskintype2diabeticpatientsaclinicalpredictiontoolbasedonalargepopulationbasedcohort
‡A
Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort
‡9
1
|
919
|
|
|
‡a
incidenttype2diabetesandhipfractureriskapopulationbasedmatchedcohortstudy
‡A
Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study.
‡9
1
|
919
|
|
|
‡a
insulinuseandexcessfractureriskinpatientswithtype2diabetesapropensitymatchedcohortanalysis
‡A
Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis.
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
RERO|A022901464
|
996
|
|
|
‡2
BAV|495_336697
|
996
|
|
|
‡2
BNC|981058604949106706
|
996
|
|
|
‡2
NTA|238031152
|
996
|
|
|
‡2
ISNI|0000000391072431
|
996
|
|
|
‡2
BNE|XX1208975
|
996
|
|
|
‡2
J9U|987012789676905171
|
996
|
|
|
‡2
NTA|074692178
|
996
|
|
|
‡2
DNB|1157778194
|
996
|
|
|
‡2
ISNI|0000000049596045
|
996
|
|
|
‡2
DBC|87097969564321
|
996
|
|
|
‡2
BNE|XX5638701
|
996
|
|
|
‡2
DNB|1057068098
|
996
|
|
|
‡2
LC|nr 93020673
|
996
|
|
|
‡2
LC|no2018113958
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|